Clinical Trial Update: Stiripentol in Dravet Syndrome

View source ↗

Summary

The clinical trial NCT01533506 evaluating stiripentol for Dravet syndrome has been withdrawn and is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dravet Syndrome

Drugs mentioned

• Stiripentol (stiripentol)

Snippet

Sponsor: Mayo Clinic | Conditions: Dravet Syndrome | Status: NO_LONGER_AVAILABLE